Review

Published on 24 Apr 2023

Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

in Cancer Cell Biology

Konstantin H. Dragnev
Christo P. C. Dragnev
Ronald A. Lubet

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1170444

1,467 views
1 citation

Review

Published on 20 Apr 2023

Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer

in Cancer Cell Biology

Ruotong Yang
Liwei Ma
Junhu Wan
Zhuofang Li
Zhengwu Yang
Zhuochen Zhao
Liang Ming

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1160381

2,896 views
5 citations

Review

Published on 20 Apr 2023

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression

in Cancer Cell Biology

Zining Zhang
Heng Zhang
Xiang Liao
Hsiang-i Tsai

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1147676

10,063 views
12 citations

Original Research

Published on 20 Apr 2023

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma

in Cancer Cell Biology

Bingxin Zhang
Quanqiang Wang
Tianyu Zhang
Ziwei Zheng
Zhili Lin
Shujuan Zhou
Dong Zheng
Zixing Chen
Sisi Zheng
Yu Zhang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1159355

4,583 views
5 citations

Review

Published on 19 Apr 2023

Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors

in Cancer Cell Biology

Siyu Zhou
Jinghan Lu
Shiyang Liu
Jiaqi Shao
Zhanwei Liu
Jianjun Li
Wan’an Xiao

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1166916

4,910 views
7 citations

Review

Published on 18 Apr 2023

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma

in Cancer Cell Biology

Jia-Mei Dong
Rui-Qi Wang
Ning-Ning Yuan
Jia-Hao Guo
Xin-Yang Yu
Ang-Hui Peng
Jia-Yi Cai
Lei Xue
Zhi-Ling Zhou
Yi-Hao Sun

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1160544

2,054 views

Mini Review

Published on 18 Apr 2023

Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies

in Cancer Cell Biology

Xingxing Xu
Zixuan Li
Xueying Yao
Nannan Sun
Junbiao Chang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1173432

3,680 views
3 citations

Original Research

Published on 17 Apr 2023

Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition

in Cancer Cell Biology

Aarren J. Mannion
Adam F. Odell
Syed Murtuza Baker
Laura C. Matthews
Pamela F. Jones
Graham P. Cook

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1129015

2,873 views

Mini Review

Published on 12 Apr 2023

CRISPR screening in cardiovascular research

in Cancer Cell Biology

Haihuan Shan
Teng Fei

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1175849

3,621 views

Mini Review

Published on 07 Apr 2023

JAZF1: A metabolic actor subunit of the NuA4/TIP60 chromatin modifying complex

in Cancer Cell Biology

Amel Mameri
Jacques Côté

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1134268

2,392 views
2 citations

Review

Published on 05 Apr 2023

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies

in Cancer Cell Biology

Vaishali Bhardwaj
Stephen M. Ansell

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1129343

3,635 views
6 citations

Original Research

Published on 05 Apr 2023

An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy

in Cancer Cell Biology

Mengling Li
Baosen Zhou
Chang Zheng

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1163314

5,698 views
7 citations

Original Research

Published on 03 Apr 2023

LncRNA model predicts liver cancer drug resistance and validate in vitro experiments

in Cancer Cell Biology

Qiushi Yin
Xiaolong Huang
Qiuxi Yang
Shibu Lin
Qifeng Song
Weiqiang Fan
Wang Li
Zhongyi Li
Lianghui Gao

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1174183

2,589 views
2 citations

Original Research

Published on 03 Apr 2023

Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma

in Cancer Cell Biology

Haiting Zhou
Yi He
Yongbiao Huang
Rui Li
Hao Zhang
Xiaohui Xia
Huihua Xiong

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1157269

2,613 views
2 citations

Original Research

Published on 31 Mar 2023

Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia

in Cancer Cell Biology

Heather A. Ogana
Samantha Hurwitz
Chih-Lin Hsieh
Huimin Geng
Markus Müschen
Deepa Bhojwani
Mark A. Wolf
James Larocque
Michael R. Lieber
Yong Mi Kim

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1134121

4,454 views
1 citation

Original Research

Published on 23 Mar 2023

Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cells

in Cancer Cell Biology

Y. Sbirkov
T. Schenk
C. Kwok
S. Stengel
R. Brown
G. Brown
L. Chesler
A. Zelent
M. J. Fuchter
K. Petrie

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1076458

4,724 views
4 citations

Navigation group

Articles

Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma

Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma

Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies

Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition

CRISPR screening in cardiovascular research

JAZF1: A metabolic actor subunit of the NuA4/TIP60 chromatin modifying complex

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies

An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy

LncRNA model predicts liver cancer drug resistance and validate in vitro experiments

Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma

Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia

Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cells